Diagnostic value of diffusion-weighted MR imaging in thyroid disease: application in differentiating benign from malignant disease

BMC Medical Imaging

Cheuk Ying Tang⁴  Xiaofeng Tao²  Ying Yuan²  Yushan Du³  Weiwen Shen³  Xiuhui Yue¹  Yingwei Wu³ 

[1]Radiology Department, Shanghai Changzheng Hospital, Shanghai, China

[2]Radiology Department, Shanghai People’s Ninth Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200011, China

[3]Radiology Department, East Hospital, Tongji University, school of Medicine, Shanghai 200120, China

[4]Radiology Department, Mount Sinai School of Medicine, New York 10029, USA

关键词: ADC mapping;    Diffusion weighted imaging;    Thyroid lesions;   

Others  :  1090854
DOI  :  10.1186/1471-2342-13-23

 received in 2012-11-06, accepted in 2013-07-19,  发布年份 2013

【 摘 要 】

Background

Fine needle aspiration biopsy is usually performed to evaluate thyroid lesions. The purpose of this study was to evaluate the usefulness of diffusion weighted imaging to differentiate malignancy of thyroid lesions.

Methods

The study was approved by ethics committee of Shanghai Changzheng Hospital.Forty-two patients, 10 men and 32 women (range: 20–72 years, mean age 42.4 years) with thyroid lesions were included in the study. Routine neck MR and diffusion-weighted MR imaging was performed using multiple b-values. ADC values were computed for the different b-values. Histological results of the thyroidectomy samples were obtained for all the patients. ADC values of benign and malignant thyroid lesions were compared with the pathology results. Logistic regression analysis was used to detect independent parameters for differentiating benign and malignancy of lesions.

Result

Based on the histology results there were 28 benign and 14 malignant cases. The difference of ADC value between benign and malignant thyroid lesions was significant for ADC values obtained using b-values of 0 and 300 s/mm² (p < 0.001). The ADC values were significantly higher in benign lesions (benign ADC: 2.37 ± 0.47 × 10-3 mm²/s vs. malignant: 1.49 ± 0.60 × 10-3 mm²/s). ADC values obtained with b-values of 0 and 300 mm²/s and max nodular diameter was regarded as the two most discriminative parameters for differentiating malignancy. Using the pathology results as a standard reference, area under ROC curve was found to be 0.876 for an ADC cutoff value of 2.17 × 10-3 mm²/s that corresponded to an acquisition with b-values of 0 and 300 mm²/s.

Conclusion

Diffusion-weighted MR imaging is a promising non-invasive method to differentiate malignancy in thyroid lesions.

【 授权许可】

   
2013 Wu et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Wong CK, Wheeler MH: Thyroid nodules: rational management. World J Surg 2000, 24:934-941.
• [2]Brander A, Viikinkoski P, Nickels J, Kivisaari L: Thyroid gland: US screening in a random adult population. Radiology 1991, 181:683-687.
• [3]Davies L, Welch HG: Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 2006, 295:2164-2167.
• [4]Mazzaferri EL, Harmer C, Mallick UK, Kendall-Taylor P: Practical management of thyroid cancer: a multidisciplinary approach. London: Springer; 2006.
• [5]Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
• [6]Bakshi NA, Mansoor I, Jones BA: Analysis of inconclusive fine-needle aspiration of thyroid follicular lesions. Endocr Pathol 2003, 14:167-175.
• [7]Koike E, Yamashita H, Noguchi S, Murakami T, Ohshima A, et al.: Effect of combining ultrasonography and ultrasound-guided fine-needle aspiration biopsy findings for the diagnosis of thyroid nodules. Eur J Surg 2001, 167:656-661.
• [8]McCoy KL, Jabbour N, Ogilvie JB, Ohori NP, Carty SE, et al.: The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size. Surgery 2007, 142:837-844. discussion 844 e831-833
• [9]Solbiati L, Osti V, Cova L, Tonolini M: Ultrasound of thyroid, parathyroid glands and neck lymph nodes. Eur Radiol 2001, 11:2411-2424.
• [10]Kiyosue H, Miyake H, Komatsu E, Mori H: MRI of cervical masses of thymic origin. J Comput Assist Tomogr 1994, 18:206-208.
• [11]Wang J, Takashima S, Takayama F, Kawakami S, Saito A, et al.: Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 2001, 220:621-630.
• [12]Eida S, Sumi M, Sakihama N, Takahashi H, Nakamura T: Apparent diffusion coefficient mapping of salivary gland tumors: prediction of the benignancy and malignancy. AJNR Am J Neuroradiol 2007, 28:116-121.
• [13]King CH, Higa AT, Culjat MO, Han SH, Bisley JW, et al.: A pneumatic haptic feedback actuator array for robotic surgery or simulation. Stud Health Technol Inform 2007, 125:217-222.
• [14]Tezuka M, Murata Y, Ishida R, Ohashi I, Hirata Y, et al.: MR imaging of the thyroid: correlation between apparent diffusion coefficient and thyroid gland scintigraphy. Journal of magnetic resonance imaging: JMRI 2003, 17:163-169.
• [15]Abdel Razek AA, Soliman NY, Elkhamary S, Alsharaway MK, Tawfik A: Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol 2006, 16:1468-1477.
• [16]Murtz P, Krautmacher C, Traber F, Gieseke J, Schild HH, et al.: Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla. Eur Radiol 2007, 17:3031-3037.
• [17]Bozgeyik Z, Coskun S, Dagli AF, Ozkan Y, Sahpaz F, et al.: Diffusion-weighted MR imaging of thyroid nodules. Neuroradiology 2009, 51:193-198.
• [18]Razek AA, Sadek AG, Kombar OR, Elmahdy TE, Nada N: Role of apparent diffusion coefficient values in differentiation between malignant and benign solitary thyroid nodules. AJNR Am J Neuroradiol 2008, 29:563-568.
• [19]Erdem G, Erdem T, Muammer H, Mutlu DY, Firat AK, et al.: Diffusion-weighted images differentiate benign from malignant thyroid nodules. Journal of magnetic resonance imaging: JMRI 2010, 31:94-100.
• [20]Anderson JR (Ed): Muir’sTextbook of Pathology. 13th edition. London: Edward Arnold; 1992.
• [21]Abdel Razek AA, Soliman NY, Elkhamary S, Alsharaway MK, Tawfik A: Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol 2006, 16:1468-1477.
• [22]Schueller-Weidekamm C, Kaserer K, Schueller G, Scheuba C, Ringl H, et al.: Can quantitative diffusion-weighted MR imaging differentiate benign and malignant cold thyroid nodules? Initial results in 25 patients. AJNR Am J Neuroradiol 2009, 30:417-422.
• [23]Schueller-Weidekamm C, Schueller G, Kaserer K, Scheuba C, Ringl H, et al.: Diagnostic value of sonography, ultrasound-guided fine-needle aspiration cytology, and diffusion-weighted MRI in the characterization of cold thyroid nodules. Eur J Radiol 2010, 73:538-544.
• [24]Herneth AM, Guccione S, Bednarski M: Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization. Eur J Radiol 2003, 45:208-213.
• [25]Delorme S, Knopp MV: Non-invasive vascular imaging: assessing tumour vascularity. Eur Radiol 1998, 8:517-527.